Increasing Emphasis on Looks to Drive the US & European Cosmetic Surgery Procedures and Products Market, According to a New Report by Global Industry Analysts, Inc.

GIA announces the release of a comprehensive report on the US and European Cosmetic Procedures and Products markets. The US market for Cosmetic Surgery Products is forecast to reach US$3.2 billion by the year 2017. Unrelenting interest to retain youthful looks coupled with growing interest towards enhancing physical appearance, continues to drive the cosmetic surgery market. In addition to the desire to look good and young, other factors driving market growth include aging population, increased competition at workplaces, growing popularity of weight loss and reality television programs, and increasing acceptance of cosmetic surgery. Technological advancements in surgical and non- surgical procedures constitute another factor driving the demand for cosmetic procedures and products.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Cosmetic Procedures and Products: A US and European Market Report

San Jose, California (PRWEB) April 27, 2012

Follow us on LinkedIn – The cosmetic surgery market is back on track in the US after witnessing declining margins, triggered by the global economic recession. The youth focused-American society, growing popularity of non-surgical procedures and continued interest to enhance their physical appearance, continues to drive the demand for cosmetic procedures and cosmetic surgery products in the region. Low cost treatment continues to remain popular among Americans. This factor holds true, particularly for injectable dermal fillers, wrinkle fillers, laser-based treatment and other less expensive cosmetic procedures. In addition, the alarming rate of overweight and obese people bodes well for procedures aimed at body contouring. Breast implants represent a key segment of the US cosmetic surgery products market, which is portended to continue its run, despite the financial crisis that vexed the US economy in the recent years. With a major advantage being the non-availability of any non-invasive alternative, the demand for implants is forecast to grow steadily. Television talk shows, reality shows, and online resources are additionally enhancing public awareness of breast implants, including silicone and saline implants. Celebrities, and cosmetic surgeons and clinics, also stand as strong factors fueling the procedural volumes. Future growth in the US breast implants market is expected to stem from anatomical breast implants, which are soaring in popularity, and by the approval of improved, more solid consistency silicone versions that would carry relatively lesser risk of rupture or leakage.

Non-surgical procedures account for a lion’s share in terms of number of procedures in the US, as stated by the new market research report on Cosmetic Procedures and Products. Though non-surgical procedures are performed in rather large numbers and are preferable due to their non-invasive nature and quick treatment times, the surgical procedures however contribute the lion's share of the cosmetic procedures and products market. Breast augmentation and the injectable Botulinum Toxin Type A (including Botox and Dysport) were the leading surgical and non-surgical cosmetic procedures performed in the year 2011, respectively. Among non-surgical treatment, demand for botox, dermal fillers (especially HA fillers), and microdermabrasion would continue to drive market growth. With more investigational non-invasive fat removal procedures, including the Smartlipo laser liposuction and cryolipolysis, expected to gain approval in the coming years, the market for non-surgical procedures is set to grow and expand further.

In terms of cosmetic surgery products, injectables represent the largest and fastest growing segment of the US cosmetic surgery products market. Key growth drivers include the non-invasive nature of these products, faster outcome, no downtime, and convenience without significant lifestyle changes often associated with surgical procedures. With more hyaluronic acid fillers expected to gain approval in the coming years, the injectables market is set to grow and expand. Increased product availability, strong marketing efforts, value-for-money, more FDA approvals, and expanding consumer interest and awareness, would continue to act as a growth engine for this segment.

In Europe, cosmetic surgery procedures account for the largest revenue share of the overall cosmetic procedures market, while non-surgical techniques outdo in terms of number of procedures performed in a year. Demand for non-surgical cosmetic procedures is significantly high, due to their non-invasiveness, reduced or no recovery time, and minimal side effects. Advancements in laser technology pushes demand beyond conventional procedures to new ones, such as laser liposuction. The UK is not only the largest market for cosmetic surgery procedures in Europe, but is also the fastest growing. Despite of turbulent economic conditions, the demand for cosmetic surgery remained unabated in the UK.

Major players profiled in the report include Allergan Inc., Anika Therapeutics Inc., Merz Aesthetics, Candela Corp., Cutera Inc., Cynosure Inc., DermaMed Solutions, Valeant Pharmaceuticals International, Inc ExcellaDerm Corp., Genesis Biosystems Inc., Johnson & Johnson, Mentor Corp., Lumenis Ltd., Medicis Pharmaceutical Corp., Palomar Medical Technologies Inc., Q-Med AB, Solta Medical Inc., Suneva Medical Inc., among others.

The research report titled "Cosmetic Procedures and Products: A US and European Market Report" announced by Global Industry Analysts Inc., provides a comprehensive review of the Cosmetic Procedures and Products market in the US, and the Cosmetic Procedures market in Europe, impact of economic recession on the markets, current market trends, major growth drivers, statistical review on popular cosmetic procedures performed in the US and European markets, recent industry activity, and profiles of major/niche US market players. The report analyzes the US market for Cosmetic Surgery Products for the years 2009 through 2017 in terms of Annual Sales for market segments including Equipment (Lasers, Microdermabrators and Other Equipment), Injectables (Botulinum Toxin Type A, Dermal Fillers, and Other Injectables), Implants (Breast Implants and Other Implants), and Others. The market analytics for the US Cosmetic Procedures for the years 2009 through 2017 are provided in terms of Annual Demand by Procedure Type, including Surgical (Breast Augmentation, Abdominoplasty, Blepharoplasty, Facelift, Liposuction, Rhinoplasty, and Others) and Non-surgical (Botox, Dermal Fillers, Laser Hair Removal, Laser Skin Resurfacing, Chemical Peel, Microdermabrasion, and Others). The report analyzes the European market for Cosmetic Procedures for years 2009 through 2017 by the following geographic regions - France, Germany, Italy, the UK, Spain, and Rest of Europe. Procedure types analyzed include Surgical Procedures (Breast Augmentation, Liposuction, Blepharoplasty and Rhinoplasty), and Non-Surgical Procedures.

For more details about this comprehensive market research report, please visit –
http://www.strategyr.com/Cosmetic_Procedures_And_Products_Market_Report.asp

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.

Follow us on LinkedIn

Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site: http://www.StrategyR.com/
###


Contact

Attachments